Here are three points:
1. The OssGro synthetic grafts complement Leader Biomedical’s existing eTiss line of human allografts used for spine, trauma and orthopedic indications.
2. The OssGro product range aims to further simulate the formation of new bone through the release of calcium and phosphate ions.
3. Leader Biomedical is a provider of biomaterials and medical implant solutions.
More articles on devices:
Bioventus gets rights to distribute GELSYN-3 in the US: 5 key notes
Nihon Kohden launches Neuromaster MEE-2000A — 5 highlights
OrthoGrid Systems releases HipGrid Drone: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.